Skip to main content
Clinical Trials/NCT02785783
NCT02785783CompletedNot Applicable

Endorings™ Assisted Colonoscopy Versus Standard Colonoscopy for Polyp Detection in Symptomatic and Asymptomatic Patients: A Randomised Controlled Trial

Portsmouth Hospitals NHS Trust1 site in 1 country563 target enrollmentStarted: May 13, 2016Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
563
Locations
1
Primary Endpoint
Number of polyps per patient

Study Overview

Brief Summary

This study evaluates the impact of Endorings™ assisted colonoscopy on the number of polyps detected per patient compared to standard colonoscopy without use of EndoRings™. Half of the participants will receive EndoRings™ assisted colonoscopy, while the other half will receive standard colonoscopy.

Detailed Description

Colonoscopy is the gold standard for detection of colorectal neoplasia (polyps and cancers) but it is well known that colonoscopy is associated with a neoplasia miss rate of up to 25%.

One such method of reducing the neoplasia miss rate is cap assisted colonoscopy, where a cap is placed at the distal end of the colonoscope.The theory behind how the cap aids mucosal visualisation is that it depresses and flattens colonic folds, thereby improving visualisation on the proximal sides of folds.

Investigators aim to evaluate the impact of one such cap assisted device: EndoRings™ on polyp detection rates. EndoRings™ has been shown to improve polyp detection rate by 51% compared to 29% for standard colonoscopy in a recent tandem endoscopy study. EndoRings™ has received FDA approval.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Diagnostic
Masking
Single (Participant)

Eligibility Criteria

Ages
55 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Symptomatic patients referred for colonoscopy age ≥
  • •Asymptomatic patients age ≥55 undergoing screening or surveillance for polyps and cancers.

Exclusion Criteria

  • •History of Inflammatory bowel disease
  • •History of Hereditary non polyposis colorectal cancer (HNPCC)
  • •Familial adenomatous polyposis syndrome (FAP)
  • •Hyperplastic polyposis syndrome
  • •Known colonic stricture

Arms & Interventions

Standard colonoscopy

Active Comparator

A standard colonoscope will be used to complete the procedure

Intervention: Standard colonoscopy (Device)

EndoRings™

Active Comparator

An EndoRings™ device will be placed at the distal end of a standard colonoscope

Intervention: EndoRings™ (Device)

Outcomes

Primary Outcomes

Number of polyps per patient

Time Frame: 14 months

To assess the impact of the Endorings™ cap on the number of polyps detected per patient as compared to standard colonoscopy.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other Gov
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials